Show simple item record

dc.contributor.authorMcCormack, M
dc.contributor.authorMcDonagh, C
dc.contributor.authorAli, M
dc.date.accessioned2024-02-05T13:06:48Z
dc.date.available2024-02-05T13:06:48Z
dc.date.issued2021-04
dc.identifier.citationMcCormack M, McDonagh C, Ali M. A progressive and severe rash - Answers. Acute Med. 2021;20(4):298-301. PMID: 35072390.en_US
dc.identifier.eissn1747-4892
dc.identifier.pmid35072390
dc.identifier.urihttp://hdl.handle.net/20.500.14200/3535
dc.description.abstractA 73-year-old female patient with epilepsy presented to hospital with a progressive, diffuse macular rash over the trunk and limbs with associated mucosal blistering and discharge. Ocular symptoms initially predominated and she was treated for presumed bacterial conjunctivitis by her General Practitioner the previous day. On the acute medical unit supportive management was initiated for suspected adverse drug reaction (ADR) to a recent lamotrigine dose increase. Skin biopsy confirmed a diagnosis of toxic epidermal necrolysis. We present this case to highlight the importance of medication history taking and raise awareness of indolent presentations of life-threatening ADRs. Caution should be applied following dose changes to anti-epileptics, even if previously stable.en_US
dc.language.isoenen_US
dc.publisherKarger Publishersen_US
dc.subjectDermatologyen_US
dc.subjectCommunicable diseasesen_US
dc.titleA progressive and severe rash - answersen_US
dc.typeArticle
dc.source.journaltitleAcute Medicine
rioxxterms.versionNAen_US
dc.contributor.trustauthorMcCormack, M
dc.contributor.trustauthorMcDonagh, C
dc.contributor.trustauthorAli, M
dc.contributor.departmentAccident and Emergencyen_US
dc.contributor.roleMedical and Dentalen_US
dc.contributor.affiliationWalsall Healthcare NHS Trusten_US
oa.grant.openaccessnaen_US


This item appears in the following Collection(s)

Show simple item record